300 related articles for article (PubMed ID: 33913314)
1. Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19 vaccine: not just PEG.
Radice A; Fassio F; Meucci E; Iorno MCL; Macchia D
Eur Ann Allergy Clin Immunol; 2021 Sep; 53(5):240-242. PubMed ID: 33913314
[No Abstract] [Full Text] [Related]
2. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
Moghimi SM
Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
[No Abstract] [Full Text] [Related]
3. Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.
Caballero ML; Quirce S
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):92-93. PubMed ID: 33433387
[No Abstract] [Full Text] [Related]
4. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.
Troelnikov A; Perkins G; Yuson C; Ahamdie A; Balouch S; Hurtado PR; Hissaria P
J Allergy Clin Immunol; 2021 Jul; 148(1):91-95. PubMed ID: 33991580
[TBL] [Abstract][Full Text] [Related]
5. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights.
Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ
Interdiscip Sci; 2021 Jun; 13(2):344-347. PubMed ID: 34021862
[TBL] [Abstract][Full Text] [Related]
6. Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine.
Hurst M; Jordan A; Capstick J; Brewerton M; Cockroft R; Ingram J
Intern Med J; 2022 Oct; 52(10):1818-1820. PubMed ID: 36000384
[TBL] [Abstract][Full Text] [Related]
7. Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine.
Sellaturay P; Nasser S; Islam S; Gurugama P; Ewan PW
Clin Exp Allergy; 2021 Jun; 51(6):861-863. PubMed ID: 33825239
[No Abstract] [Full Text] [Related]
8. Macrogol hypersensitivity in multiple drug allergy.
Bommarito L; Mietta S; Nebiolo F; Geuna M; Rolla G
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):542-3. PubMed ID: 22123387
[No Abstract] [Full Text] [Related]
9. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
[No Abstract] [Full Text] [Related]
10. Allergy to COVID-19 vaccines: A current update.
Cabanillas B; Novak N
Allergol Int; 2021 Jul; 70(3):313-318. PubMed ID: 33962863
[TBL] [Abstract][Full Text] [Related]
11. Allergic Reactions to COVID-19 Vaccines: An Allergist's Perspective.
Cruz C; Gaspar Â; Borrego LM
Acta Med Port; 2021 Mar; 34(3):243. PubMed ID: 33547771
[No Abstract] [Full Text] [Related]
12. Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports.
Mustafa SS; Ramsey A; Staicu ML
Ann Intern Med; 2021 Aug; 174(8):1177-1178. PubMed ID: 33819057
[No Abstract] [Full Text] [Related]
13. Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines.
Mouri M; Imamura M; Suzuki S; Kawasaki T; Ishizaki Y; Sakurai K; Nagafuchi H; Matsumura N; Uchida M; Ando T; Yoshioka K; Ooka S; Sugihara T; Miyoshi H; Mori M; Okada T; Yamaguchi M; Kunishima H; Kato M; Kawahata K
Allergol Int; 2022 Oct; 71(4):512-519. PubMed ID: 35718709
[TBL] [Abstract][Full Text] [Related]
14. Vaccine allergy: evidence to consider for COVID-19 vaccines.
Nilsson L; Csuth Á; Storsaeter J; Garvey LH; Jenmalm MC
Curr Opin Allergy Clin Immunol; 2021 Aug; 21(4):401-409. PubMed ID: 34091550
[TBL] [Abstract][Full Text] [Related]
15. Immediate-Type Hypersensitivity to Polyethylene Glycol (PEG) and a PEG-Containing COVID-19 Vaccine Revealed by Intradermal Testing.
Pickert J; Hennighausen I; Mühlenbein S; Möbs C; Pfützner W
J Investig Allergol Clin Immunol; 2021 Dec; 31(6):526-527. PubMed ID: 34132638
[No Abstract] [Full Text] [Related]
16. Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivity.
Zarnegar-Lumley S; Stone CA; Smith CM; Hall LL; Luck KE; Koo G; Plager JH; Phillips EJ; Friedman DL
Pediatr Blood Cancer; 2022 Jul; 69(7):e29686. PubMed ID: 35353440
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients.
Bruusgaard-Mouritsen MA; Johansen JD; Garvey LH
Clin Exp Allergy; 2021 Mar; 51(3):463-470. PubMed ID: 33394522
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis.
Greenhawt M; Shaker M; Golden DBK; Abrams EM; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Chu DK; Dwamena BA
Allergy; 2023 Jan; 78(1):71-83. PubMed ID: 36321821
[TBL] [Abstract][Full Text] [Related]
19. Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report.
Pitlick MM; Sitek AN; Kinate SA; Joshi AY; Park MA
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):735-738. PubMed ID: 33775902
[No Abstract] [Full Text] [Related]
20. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
Garvey LH; Nasser S
Br J Anaesth; 2021 Mar; 126(3):e106-e108. PubMed ID: 33386124
[No Abstract] [Full Text] [Related]
[Next] [New Search]
